HARROW INC. - COMMON STOCK

Harrow Health to Announce Second Quarter 2021 Financial Results on August 10, 2021

26 Jul 2021 09:00:00 By Nasdaq GlobeNewswire

Harrow Health Granted Two Patents for Novel Surgical Dilation Formulation

15 Jul 2021 08:00:01 By Nasdaq GlobeNewswire

Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026

17 Jun 2021 16:01:00 By Nasdaq GlobeNewswire

Harrow Health Announces Pricing of $17.5 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026

14 Jun 2021 17:59:19 By Nasdaq GlobeNewswire

Harrow Health Announces Offering of $17.5 Million of 8.625% Senior Notes Due 2026 and “BB” Rating from Egan-Jones

14 Jun 2021 07:45:00 By Nasdaq GlobeNewswire

Harrow Health Launches New Corporate and Investor Website

01 Jun 2021 09:00:00 By Nasdaq GlobeNewswire

Leading Peer-Reviewed Ophthalmic Journal Publishes Study on ImprimisRx’s Proprietary Klarity-C® Drops

17 May 2021 09:00:00 By Nasdaq GlobeNewswire

Harrow Health Announces Record First Quarter 2021 Financial Results

11 May 2021 16:01:00 By Nasdaq GlobeNewswire

Harrow Health Raises Approximately $11 Million in Sale of Series B Preferred Stock

05 May 2021 16:03:00 By Nasdaq GlobeNewswire

Harrow Health Announces Full Exercise and Closing of Option to Purchase Additional Senior Notes

05 May 2021 16:01:00 By Nasdaq GlobeNewswire

Harrow Health to Announce First Quarter 2021 Financial Results on May 11, 2021

27 Apr 2021 09:00:01 By Nasdaq GlobeNewswire

Harrow Health Announces Closing of $50 Million Offering of Senior Notes Due 2026

20 Apr 2021 16:01:00 By Nasdaq GlobeNewswire

Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026

15 Apr 2021 17:00:00 By Nasdaq GlobeNewswire

Harrow Health Announces Offering of $25 Million Senior Notes Due 2026 and “BB” Rating from Egan-Jones

14 Apr 2021 16:01:00 By Nasdaq GlobeNewswire

Harrow Health Announces Preliminary First Quarter 2021 Financial Results

14 Apr 2021 16:00:00 By Nasdaq GlobeNewswire

Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results

08 Mar 2021 16:01:00 By Nasdaq GlobeNewswire

Harrow Health to Participate in H.C. Wainwright Global Life Sciences Conference

02 Mar 2021 09:00:01 By Nasdaq GlobeNewswire

Harrow Health to Announce Fourth Quarter and Year-End 2020 Financial Results on March 8, 2021

25 Feb 2021 09:00:01 By Nasdaq GlobeNewswire

Melt Pharmaceuticals Completes Phase 1 Study for Sublingual, Non-Opioid Pain and Sedation Drug Candidate

09 Feb 2021 07:00:00 By Nasdaq GlobeNewswire